Al-Ghorbani, M.;                     Alharbi, O.;                     Al-Odayni, A.-B.;                     Abduh, N.A.Y.    
        Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals 2023, 16, 1222.
    https://doi.org/10.3390/ph16091222
    AMA Style
    
                                Al-Ghorbani M,                                 Alharbi O,                                 Al-Odayni A-B,                                 Abduh NAY.        
                Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals. 2023; 16(9):1222.
        https://doi.org/10.3390/ph16091222
    
    Chicago/Turabian Style
    
                                Al-Ghorbani, Mohammed,                                 Osama Alharbi,                                 Abdel-Basit Al-Odayni,                                 and Naaser A. Y. Abduh.        
                2023. "Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes" Pharmaceuticals 16, no. 9: 1222.
        https://doi.org/10.3390/ph16091222
    
    APA Style
    
                                Al-Ghorbani, M.,                                 Alharbi, O.,                                 Al-Odayni, A.-B.,                                 & Abduh, N. A. Y.        
        
        (2023). Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals, 16(9), 1222.
        https://doi.org/10.3390/ph16091222